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1. Introduction
   Sickle cell disease (SCD) or sickle cell anemia is a genetic 
disease that affects particularly the tropical areas. The 
disease is due to a replacement of glutamic acid located 
in the sixth position of the β chain of hemoglobin by 
valine[1,2].
   This amino acid substitution alters not only the affinity of 
hemoglobin for oxygen but also its solubility in low oxygen 
pressure conditions. The decrease of solubility causes 
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Objective: To perform phytochemical analyses on the leaves of Ocimum basilicum L. (O. 
basilicum), to elucidate the structure of isolate and then perform the antisickling activity on the 
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Methods: The Emmel test performed on the acidified methanolic extract of this plant was used 
to evaluate the antisickling activity. The structure characterization of the active compound was 
performed using chromatographic techniques for the separation and the spectroscopic ones for 
structure elucidation (1H-NMR, 13C-NMR, COSY, HMBC).
Results: The chemical screening on the crude extract revealed the presence of polyphenols 
(flavonoids, anthocyanins, leucoanthocyanins, tannins, quinones) alkaloids, saponins, 
triterpenoids and steroids. The obtained extract after evaporation yielded 34.50 g (11.5%) out of 300 
g of powdered leaves of O. basilicum. The acidified methanolic extract and butyl stearate showed 
an interesting antisickling activity.
Conclusions: The acidified methanolic extract and butyl stearate from O. basilicum displayed 
a good antisickling activity. To the best of our knowledge, this is the first time to report the 
antisickling activity of this compound in this plant. The synthesized compound presented the 
same spectroscopic characteristics than the natural one and the antisickling activities of its 
derivatives are understudying. 
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polymerization of hemoglobin and the sickling of red blood 
cells. This is the basis of many symptoms that sicklers 
suffer[1,3].
   SCD affects each year nearly five million people in the 
world. In some parts of Africa, the sickle cell trait is up to 
20% of the population with the prevalence in Central Africa 
of 25% to 30%[1]. More than 200 000 children with sickle cell 
disease are born each year in Africa[4].
   Two percent of the populations, more than one million[5,6], 
in the Democratic Republic of the Congo (DRC) are affected 
by this disease. Nearly 80% of children affected by this 
anemia die before they are five years old if they are not 
followed medically[1,2,7,8].
   The percentage of people suffering from this disease 
continues to grow. Therefore, sickle cell becomes a real 
public health problem in endemic areas[4]. It then becomes 
increasingly crucial to intensify early detection and to 
examine the search for new affordable treatments. 
   Several therapies have been proposed, the bone marrow 
transplantation, gene therapy, repeated blood transfusions, 
use of hydroxyurea, etc. But it turns out that these 
treatments are not only ineffective and very expensive for 
the poor African populations, but may also constitute a risk 
of HIV/AIDS[2,9,10].
   Recently, several studies have dealt with the use of 
medicinal plants to treat SCD[11-14].
   In DRC, recent findings have shown that at least 60 
medicinal plants used in traditional medicine to treat SCD, 
among which Ocimum basilicum (O. basilicum), posses 
in vitro antisickling activity[5,6,9,15-19]. Those previous 
results showed that this activity could mainly be due to the 
presence of anthocyanins in the plants[2,5,6,15-17,20,21].
   Some molecules isolated from plants, including 
p-hydroxy benzoic acid, Zanthoxylol, betulinic acid ... 
have shown in vitro interesting activity against SCD[22,23]. 
Betulinic acid may thus be used as a positive control in 
antisickling activity assessment. 
   The present work is aimed to perform phytochemical 
analyses on the leaves of O. basilicum and  to elucidate the 
structure of the leaves bioactive compound.
2. Materials and methods
2.1. Plant material
   O. basilicum leaves were harvested in the University of 
Kinshasa surroundings from May to June 2011. The plant was 
authenticated by Mr. Nlandu (Specimen voucher number 
425) and deposited at the herbarium of Institut National des 
Recherches Agronomiques (INERA), the Faculty of Sciences 
of the University of Kinshasa. 
2.2. Biological material
   The homozygote HbS/HbS (SS) blood sample used to 
evaluate the biological activity was obtained from patients 
after their preventive treatment at the Centre de Médecine 
Mixte et d’Anémie SS, located in Kinshasa area, DRC. None 
of the patients had been transfused recently with homozygote 
HbA/HbA (AA) blood. All antisickling experiments were 
carried out with freshly collected blood. In order to confirm 
their SS nature, the above-mentioned blood samples were 
first characterized by haemoglobin electrophoresis on 
cellulose acetate gel at pH 8.5. They were found to be SS 
blood and were then stored in a refrigerator at 4 °C.
2.3. Extraction in acidified methanol
   The dried and powdered plant material (leaves, 300 g) were 
soaked in 1 L of methanol and acidified with hydrochloric 
acid 0.4 mol/L and then concentrated to dryness under 
reduced pressure using a rotary evaporator. The residue 
was then extracted using petroleum ether and dried at 50 °C 
in the oven (Brand MEMMERT model).
   Chemical screening was performed in aqueous and 
organic extracts according to a well known protocol.
2.4. Fractionation of the acidified methanolic extract
   The thin layer chromatography with silica gel was carried 
out on the acidified methanolic extract using the mixture of 
n-butanol-acetic acid-water (4-1-5) as eluting system and 
the UV lamp (type CAMAG) at 366 nm as a developer[24,25].
   Preparative chromatography was performed on glass 
plates 20 cm伊20 cm on which was spread P/UV254 silica gel. 
These plates were dried at 105 °C for 48 h in the oven.
   Column chromatography was then carried out to isolate 
the mixtures from the preparative chromatography, using 
silica gel (Kieselgel brand 60 F254; 0.2-0.5 nm/35-70 100 
mesh) and the mixture of n-butanol/n-hexane (8:2) as 
eluting system.
2.5. Spectroscopic analyses
   The structure elucidation of the compound isolated from 
the extract was done using 1D-NMR (1H-NMR, 13C-NMR), 2D-
NMR (COSY, HMBC) and mass spectrum at high resolution.
   NMR spectra were recorded using the spectrometer Bruker 
Avance 300 MHz type. All spectra were taken at room 
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temperature using deuterated chloroform and read from the 
reference line deuterated chloroform which is δH 7.24 ppm 
and δC 77.20 ppm. The sample was solubilized in deuterated 
choloroform (CDCl3). The chemical shifts (δ) are expressed in 
ppm relative to tetramethylsilane.
   The mass spectrometry was performed using the device 
“GCT Premier instrument”. The compound was dissolved 
in methanol (1:100) used for HPLC, and helium (0.8 mL/min) 
used as elution gas was maintained at 200 °C for 4 min and 
then programmed up to 300 °C, increasing the temperature 
by 5 °C a min. Ionization was done by electron impact and 
the analyzer was used high-resolution time of flight.
2.6. Antisickling activity
   The blood sample was mixed with the crude extract 
and the isolate, using physiological saline as solvent. The 
Emmel test was performed to evaluate the antisickling 
activity[2]. Microscopic images were examined under an 
optical microscope brand Bresser Biolux NV 20X-1280X. 
Microscopic images were processed using the software 
IMAGE MOTIC 2000 version 1.3.
3. Results 
3.1 Antisickling activity of aqueous crude extracts of O. 
basilicum leaves
   Figure 1, 2 and 3 provide digital images of respectively 
SS blood alone (negative control), of the SS blood treated 
with betulinic acid (positive control) and of that treated with 
acidified methanol extract. 
Figure 1. Morphology of drepanocytes of SS blood (Negative control) [NaCl 
0.9%, Na2S2O5 2% 伊500].    
Figure 2. Morphology of drepanocytes treated  with betulinic acid (positive 
control) [NaCl 0.9%, Na2S2O5 2% 伊500].
Figure 3. Morphology of drepanocytes treated with aqueous extract [NaCl 
0.9%, Na2S2O5 2% 伊500].
3.2 Phytochemical screening and extraction yield
   The phytochemical screening on the crude extract revealed 
the presence of polyphenols (flavonoids, anthocyanins, 
leucoanthocyanins, tannins, quinones), alkaloids, saponins, 
triterpenoids and steroids.
   The obtained extract after evaporation yielded 34.50 g 
(11.5%) out of 300 g of powdered leaves of O. basilicum. 
The acidified methanolic extract showed an interesting 
antisickling activity.
3.3 Antisickling activity of acidified methanolic extract and the 
isolate
   Figures 4 and 5 give the phenotype of SS red blood cells 
treated with the acidified methanolic extract and the isolate, 
Dorothée Dinangayi TSHILANDA et al./Asian Pac J Trop Biomed 2014; 4(5): 393-398396
respectively. 
Figure 4. Morphology of drepanocytes treated with acidified methanolic 
extract [NaCl 0.9%, Na2S2O5 2% 伊500].
Figure 5. Morphology of drepanocytes with treated with the isolated 
compound  [NaCl 0.9%, Na2S2O5 2% x500].   
   Calculated average of radius, perimeter and surface of 
drepanocytes before and after treatment with the isolated 
compound are given in Table 1.
Table 1
Average values of radius, perimeter and surface of erythrocytes before 
and after treatment the isolated compound (ICD) of O. basilicum.
Measured parameters Untreated SS RBCs SS RBCs (+ICD)
Radius (µm) -  3.1±0.3
Perimeter (µm) 31.7±1.5 18.3±1.1
Surface (µm2) 19.2±1.0 31.8±1.7
RBCs: Red blood cells
3.4. Chromatographic analysis and spectroscopic 
characteristics of the isolate 
   Chromatographic analysis on the methanolic extract 
allowed to obtain at Rf: 0.71, a viscous brown product, 
fluorescent at UV lamp at 366 nm, with a b.p. of 222-224 °C.
   1H-NMR spectrum (CDCl3) showed characteristic peaks at 
δH: 4.064 ppm (t), 2.28 ppm (t); 0.93 ppm (t), 0.88 ppm (t) and 
1.65 ppm to 1.31 ppm.
   The 13C-NMR spectrum showed 15 characteristic peaks at 
δC:174.0 ppm,  64.1 ppm, 34.4 ppm, 31.9 ppm, 30.7 ppm, 29.7 
ppm, 29.6 ppm, 29.5 ppm, 29.3 ppm, 29.2 ppm, 25.0 ppm,  22.1 
ppm, 19.1 ppm, 14.1 ppm, 13.7 ppm and a characteristic peak 
of great intensity at  29.7 ppm.
   The mass spectrum, performed in electron impact 
ionization (EI) positive mode showed the molecular ion peak 
M+• at m/z:  340.334 5  and other peaks respectively at: 312.3, 
257.2, 239.2, 213.18 and 199.17.
4. Discussion
4.1. Antisickling activity of O. basilicum leaves crude extracts
   The majority of RBCs are elongated (sickled) confirming that 
the used blood is SS one. When betulinic (positive control) is 
added, RBCs show circular (biconcave) and normal shape. In 
the presence of the aqueous extract of O. basilicum, the RBCs 
have circular (biconcave) and normal shape, which is similar 
to the positive control, indicating the antisickling effect of the 
extract. This confirms previous work of our research team[5,6,20] 
and justifies the use of this plant in Congolese folk medicine.
4.2. Phytochemical composition and Antisickling activity of 
acidified methanolic extract and that of the isolate.
   Phytochemical screening of O. basilicum leaves confirms 
previous works[18]. It was also indicates that polar extracts are 
more active on sickle blood cell that non polar one[2,11,15-18 
]. So antisickling activity of acidified methanolic extract was 
tested  and fractioned. Bio guided tests were done on  some 
fractions. Most of the red blood cells have recovered their 
normal and circular shapes under hypoxic conditions. This 
indicates the antisickling activity of the acidified methanolic 
extract and the isolate. These results can be quantified by 
calculating mean radius, perimeters and surfaces before and 
after RBCs treatment.
   The used software could not calculate the average radius for 
the RBCs of the sickle blood since sickled RBCs of untreated 
blood are not circular. The average radius appeared after 
treatment of sickle RBCs with isolated compound indicating 
the re-appearance of the normal form of RBCs. Statistical 
treatment (Student test applied with a probability threshold 
of 0.05) enabled the determination of a significant difference 
between the average values of both the perimeter and the 
surface of blood cells on the micrography, thus confirming 
the modification RBCs morphology in the presence of the 
isolated compound. This behavior was already observed for 
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some extracts from other Congolese plants[2,7,8,18,19]. 
4.3. Structure elucidation of the isolate
   The analysis of the 1H-NMR spectrum indicates that 
characteristic peaks at δH: 4.064 ppm (t) and 2.28 ppm (t) 
represent the -CH2- groups respectively adjacent to the 
oxygen of the ester and to the carbonyl. The peaks at δH: 
0.93 ppm (t) and 0.88 ppm (t) are characteristic of CH3 groups, 
respectively one that ends the methylene oxygen binder 
and the one ending those related to the carbonyl of the ester 
function, while those of δH: 1.65 ppm to 1.31 ppm represent 
the -CH2- groups between the long hydrocarbon chain 
methylene group linked to the carbonyl. These values are 
similar to those found in the literature[26].
   In comparison of the literature[26] ,the 15 characteristic 
peaks of 13C-NMR spectrum can be assigned as follows: C1 
(δC 174.0 ppm), C2 (δC 64.1 ppm), C3 (δC 34.4 ppm ), C4 (δC 31.9 
ppm), C5 (δC 30.7 ppm), C6 (δC 29.7 ppm) C7 (δC 29.6 ppm), 
C8 (δC 29.5 ppm), C9 (δC 29.3 ppm), C10 (δC 29.2 ppm) C11 (δC 
25.0 ppm), C12 (δC 22.1 ppm), C13 (δC 19.1 ppm), C14 (δC 14.1 
ppm), C15 (δC 13.7 ppm), and the  characteristic peak of great 
intensity at δC 29.7ppm correspond to 8 methylene groups.
   The mass spectrum gives an ion peak M+• at m/z: 340.3345 
corresponding to butyl stearate mass. This correlates with the 
literature[26]. According to this literature, the compound was 
identified as butyl stearate. 
   This compound was synthesized and presented the same 
spectroscopic characteristics than the natural one.
   O. basilicum, one of the plants used in Congolese 
traditional medicine against sickle cell anemia has shown 
antisickling activity and butyl stearate isolated from this 
plant could be the main active compound. To the best of our 
knowledge, this is the first time to report the antisickling 
activity of this compound in this plant. The synthesized 
compound presented the same spectroscopic characteristics 
than the natural one. Antisickling activities of its derivatives 
are understudying. 
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Comments 
Background
   SCD is a blood disease characterized by the aggregation of 
hemoglobin S under hypoxic conditions. Its symptoms are 
erythrocytes shape modification and anemia. The need to 
search for new drugs with low toxicity is the new challenges. 
The plant kingdom could serve as a source of the anti-
sickling new lead compounds as herein demonstrated.
  
Research frontiers
   The present research work depicts in vitro anti-sickling 
activity and phytochemical analyses on the leaves of O. 
basilicum. Biological testing was assessed by evaluating the 
effect of plant extracts and its isolate on the sickle erythrocytes 
phenotype/morphology. The structure of the isolate was 
elucidated using 1D-NMR (1H-NMR, 13C-NMR), 2D-NMR (COSY, 
HMBC) and mass spectroscopy at high resolution.
Related reports
   There are several reports on the biological activities of this 
medicinal plant species as antimicrobial and antioxidant. 
This is the first time report on the anti-sickling activity of 
butyl stearate isolated from O. basilicum.
Innovations and breakthroughs
   O. basilicum leaves are widely used in the Congolese 
traditional medicine to treat SCD. In the present research 
study, the authors isolated for the first time butyl stearate 
from O. basilicum and reported for the first time its anti-
sickling activity.    
  
Applications
   The pharmaceutical relevance of findings from this study 
derives from the possibility of formulating O. basilicum as an 
anti-sickling herbal medicine to be used in regions where 
SCD is endemic. The identification of the active principle 
could enhance the standardization of recipe.  
Peer review
   This is a valuable study in which the authors have isolate 
and characterized butyl stearate ester from O. basilicum 
as a new anti-sickling agent. The activity was assessed 
based on the sickling of red blood cells. Plant extracts and 
butyl stearate demonstrated remarkable sickling inhibitory 
effects. Treated sickle erythrocytes displayed a very similar 
phenotype/morphology than that of the normal erythrocytes 
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one. O. basilicum is then promising source of anti-sickling 
new lead compounds.      
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